AT358202B - Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons - Google Patents

Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons

Info

Publication number
AT358202B
AT358202B AT703577A AT703577A AT358202B AT 358202 B AT358202 B AT 358202B AT 703577 A AT703577 A AT 703577A AT 703577 A AT703577 A AT 703577A AT 358202 B AT358202 B AT 358202B
Authority
AT
Austria
Prior art keywords
predisolon
chlored
producing new
new derivatives
derivatives
Prior art date
Application number
AT703577A
Other languages
English (en)
Other versions
ATA703577A (de
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2645105A external-priority patent/DE2645105C2/de
Priority claimed from DE19772742982 external-priority patent/DE2742982C2/de
Application filed by Schering Ag filed Critical Schering Ag
Priority to AT796879A priority Critical patent/AT373603B/de
Priority to AT0796779A priority patent/AT369387B/de
Priority to AT796979A priority patent/AT373604B/de
Publication of ATA703577A publication Critical patent/ATA703577A/de
Application granted granted Critical
Publication of AT358202B publication Critical patent/AT358202B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT703577A 1976-10-04 1977-10-03 Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons AT358202B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT796879A AT373603B (de) 1976-10-04 1979-12-18 Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
AT0796779A AT369387B (de) 1976-10-04 1979-12-18 Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
AT796979A AT373604B (de) 1976-10-04 1979-12-18 Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2645105A DE2645105C2 (de) 1976-10-04 1976-10-04 Derivate des 9-Chlorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Präparat
DE19772742982 DE2742982C2 (de) 1977-09-21 1977-09-21 9-Chlorprednisolon-Derivate, Verfahren zu deren Herstellung und diese enthaltendes pharmazeutisches Präparat

Publications (2)

Publication Number Publication Date
ATA703577A ATA703577A (de) 1980-01-15
AT358202B true AT358202B (de) 1980-08-25

Family

ID=25770978

Family Applications (1)

Application Number Title Priority Date Filing Date
AT703577A AT358202B (de) 1976-10-04 1977-10-03 Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons

Country Status (21)

Country Link
JP (1) JPS5359654A (de)
AT (1) AT358202B (de)
CH (4) CH630098A5 (de)
DK (1) DK438277A (de)
ES (1) ES462887A1 (de)
FI (1) FI58645C (de)
FR (1) FR2366313A1 (de)
GB (1) GB1594852A (de)
GR (1) GR73041B (de)
HU (1) HU179593B (de)
IE (1) IE45877B1 (de)
IL (1) IL53030A (de)
IT (1) IT1113623B (de)
LU (1) LU78223A1 (de)
NL (1) NL7710869A (de)
NO (1) NO148597C (de)
NZ (1) NZ185295A (de)
PL (1) PL110392B1 (de)
PT (1) PT67109B (de)
SE (1) SE431655B (de)
SU (2) SU743581A3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2853785A1 (de) * 1978-12-11 1980-06-19 Schering Ag Neue prednison-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung
JPH0374245A (ja) * 1989-08-12 1991-03-28 Mk Seiko Co Ltd 洗車機
CA2792646C (en) 2010-03-26 2018-11-20 Galderma Research & Development Improved uses and compositions for safe and effective treatment of erythema
EP2768502A2 (de) 2011-10-19 2014-08-27 Galderma S.A. Verfahren zur verringerung gesichtsrötung mittels systematischer verwendung von phosphodiesterase-typ 5-hemmern
CN106632561A (zh) * 2016-12-16 2017-05-10 广州仁恒医药科技股份有限公司 一种二氟泼尼酯的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH429716A (de) * 1961-06-24 1967-02-15 Vismara Francesco Spa Verfahren zur Herstellung von 17a-Acyloxy-21-hydroxy-Steroiden
DE2055221A1 (en) * 1970-11-10 1972-05-18 Laboratorio Chimico Farmaceutico Dr. P. Blasina S.R.L., Mailand (Italien) 17-acyloxy-3-keto-pregn-4-enes prepn - by acylating 17-hydroxy steroids in presence ofstannic chloride

Also Published As

Publication number Publication date
IT1113623B (it) 1986-01-20
CH632772A5 (en) 1982-10-29
JPS6129960B2 (de) 1986-07-10
FR2366313B1 (de) 1980-02-01
FI58645B (fi) 1980-11-28
SU743581A3 (ru) 1980-06-25
GB1594852A (en) 1981-08-05
NO148597C (no) 1983-11-09
ES462887A1 (es) 1978-12-16
PL110392B1 (en) 1980-07-31
FI772922A (fi) 1978-04-05
SE7711039L (sv) 1978-04-05
LU78223A1 (de) 1978-02-01
CH631997A5 (en) 1982-09-15
IE45877B1 (en) 1982-12-15
JPS5359654A (en) 1978-05-29
ATA703577A (de) 1980-01-15
IL53030A0 (en) 1977-11-30
PT67109B (de) 1979-03-14
SE431655B (sv) 1984-02-20
CH632278A5 (en) 1982-09-30
FI58645C (fi) 1981-03-10
NL7710869A (nl) 1978-04-06
CH630098A5 (en) 1982-05-28
DK438277A (da) 1978-04-05
IL53030A (en) 1982-11-30
HU179593B (en) 1982-11-29
SU751327A3 (ru) 1980-07-23
PT67109A (de) 1977-11-01
GR73041B (de) 1984-01-26
NZ185295A (en) 1980-04-28
NO773362L (no) 1978-04-05
NO148597B (no) 1983-08-01
IE45877L (en) 1978-04-04
PL201161A1 (pl) 1979-01-29
FR2366313A1 (fr) 1978-04-28

Similar Documents

Publication Publication Date Title
AT351164B (de) Verfahren zur herstellung von neuen cephalos- porinderivaten
AT360005B (de) Verfahren zur herstellung von neuen sulfonyl- benzimidazolderivaten
AT362085B (de) Verfahren zur herstellung von neuen 16- -dehydroandrostan-derivaten
AT344163B (de) Verfahren zur herstellung von neuen oxadiazolinon-derivaten
AT360006B (de) Verfahren zur herstellung von neuen thiazolinylbenzimidazolderivaten
AT357274B (de) Verfahren zur herstellung von neuen derivaten des 20,21-dinoreburnamenins
AT347453B (de) Verfahren zur herstellung von neuen 5-phenyl- oxazolidinon-2-derivaten
AT352120B (de) Verfahren zur herstellung von neuen benzoxocin- derivaten
AT357693B (de) Verfahren zur herstellung von neuen ergolen- -derivaten
AT352281B (de) Verfahren zur herstellung von neuen disaccharidderivaten von anthracyclinen
AT356655B (de) Verfahren zur herstellung von neuen benzodia- zepinderivaten
AT358202B (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
AT352921B (de) Verfahren zur herstellung von neuen dipeptid- derivaten
AT347937B (de) Verfahren zur herstellung von neuen sulfonylbenzimidazol-derivaten
AT365567B (de) Verfahren zur herstellung von neuen derivaten des s-carboxybenzyl-l-cysteins
AT343291B (de) Verfahren zur herstellung von neuen quartaren xanthinylalkyl-nortropinderivaten
AT361928B (de) Verfahren zur herstellung von neuen chinolonderivaten
AT350555B (de) Verfahren zur herstellung von neuen additions- salzen von thiazol-5-methanolderivaten
AT373603B (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
ATA796779A (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
ATA796979A (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
AT362349B (de) Verfahren zur herstellung von neuen 3-amino-2- -hydroxypropoxyaryl-derivaten
ATA706679A (de) Verfahren zur herstellung von neuen derivaten des 4-hydroxi-thiazolidin-2-thions
ATA893377A (de) Verfahren zur herstellung von neuen thieno- thiazinderivaten
AT361466B (de) Verfahren zur herstellung von neuen tiophen- derivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee